Cargando…
Puerarin improves graft bone defect through microRNA-155-3p-mediated p53/TNF-α/STAT1 signaling pathway
Bone graft defects may lead to dysfunction of bone regeneration and metabolic disorders of bone mesenchymal stem cells (BMSCs). Puerarin has demonstrated pharmacological activities in the treatment of human metabolic diseases. The purpose of the present study was to investigate the role of puerarin...
Autores principales: | Zhou, Yang, Lian, Hongyu, Liu, Kexin, Wang, Deli, Xiu, Xuelian, Sun, Zhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255454/ https://www.ncbi.nlm.nih.gov/pubmed/32377717 http://dx.doi.org/10.3892/ijmm.2020.4595 |
Ejemplares similares
-
Teratogen-induced alterations in microRNA-34, microRNA-125b and microRNA-155 expression: correlation with embryonic p53 genotype and limb phenotype
por: Gueta, Keren, et al.
Publicado: (2010) -
Effects of Puerarin Combined with PLGA/TCP/Puerarin on Osteocalcin and Sialoprotein of Mandibular Defects
por: Guo, Ying, et al.
Publicado: (2022) -
Phosphorylation of p53 at threonine 155 is required for Jab1-mediated nuclear export of p53
por: Lee, Eun-Woo, et al.
Publicado: (2017) -
Modulation of Mismatch Repair and the SOCS1/p53 Axis by microRNA-155 in the Colon of Patients with Primary Sclerosing Cholangitis
por: Adamowicz, Monika, et al.
Publicado: (2022) -
Puerarin in inducing apoptosis of bladder cancer cells through inhibiting SIRT1/p53 pathway
por: Ye, Guomei, et al.
Publicado: (2019)